4.7 Article

Automated Annotation of Epileptiform Burden and Its Association with Outcomes

期刊

ANNALS OF NEUROLOGY
卷 90, 期 2, 页码 300-311

出版社

WILEY
DOI: 10.1002/ana.26161

关键词

-

资金

  1. Sage Therapeutics
  2. NIH National Institute of Neurological Disorders and Stroke [K23NS114201, K23NS105950, 1R01NS102190, 1R01NS102574, 1R01NS107291, 1RF1AG064312]

向作者/读者索取更多资源

This study aimed to investigate the dose-response relation between epileptiform activity burden and outcomes in acutely ill patients. By analyzing EEG data from nearly 2000 patients, the study found an independent association between peak epileptiform burden and poor outcomes. Machine learning methods were effective in evaluating the impact of epileptiform activity burden on outcomes.
Objective This study was undertaken to determine the dose-response relation between epileptiform activity burden and outcomes in acutely ill patients. Methods A single center retrospective analysis was made of 1,967 neurologic, medical, and surgical patients who underwent >16 hours of continuous electroencephalography (EEG) between 2011 and 2017. We developed an artificial intelligence algorithm to annotate 11.02 terabytes of EEG and quantify epileptiform activity burden within 72 hours of recording. We evaluated burden (1) in the first 24 hours of recording, (2) in the 12-hours epoch with highest burden (peak burden), and (3) cumulatively through the first 72 hours of monitoring. Machine learning was applied to estimate the effect of epileptiform burden on outcome. Outcome measure was discharge modified Rankin Scale, dichotomized as good (0-4) versus poor (5-6). Results Peak epileptiform burden was independently associated with poor outcomes (p < 0.0001). Other independent associations included age, Acute Physiology and Chronic Health Evaluation II score, seizure on presentation, and diagnosis of hypoxic-ischemic encephalopathy. Model calibration error was calculated across 3 strata based on the time interval between last EEG measurement (up to 72 hours of monitoring) and discharge: (1) <5 days between last measurement and discharge, 0.0941 (95% confidence interval [CI] = 0.0706-0.1191); 5 to 10 days between last measurement and discharge, 0.0946 (95% CI = 0.0631-0.1290); >10 days between last measurement and discharge, 0.0998 (95% CI = 0.0698-0.1335). After adjusting for covariates, increase in peak epileptiform activity burden from 0 to 100% increased the probability of poor outcome by 35%. Interpretation Automated measurement of peak epileptiform activity burden affords a convenient, consistent, and quantifiable target for future multicenter randomized trials investigating whether suppressing epileptiform activity improves outcomes. ANN NEUROL 2021

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据